The overall day mortality rate was Sixty-eight patients received empirical treatment with linezolid, and 1, received glycopeptides. In order to compare the mortality rates between patients who received linezolid or glycopeptides, the propensity scores on baseline variables were used to balance the treatment groups, and both propensity score matching and propensity-adjusted logistic regression were used to compare the day mortality rates between the groups. For this purpose, 1, patients with Gram-negative bacteremia in the Hospital Clinic of Barcelona from to were included in this study. The aim of this study was to evaluate the influence of empirical use of linezolid or glycopeptides in addition to other antibiotics on the day mortality rates in patients with Gram-negative bacteremia. The role of linezolid in empirical therapy of suspected bacteremia remains unclear.
0 Comments
Leave a Reply. |